CXCR1 and neoplasm: In mouse models, blocking CXCR1/2 significantly reduced the recruitment of neutrophils and myeloid-derived suppressor cells (MDSCs) to the tumor microenvironment, thereby reducing immune suppression and enhancing the anti-tumor immune response.